You may know Pfizer (NYSE: PFE) for its blockbuster coronavirus vaccine. Pfizer may face a bit of a near-term slowdown in revenue. In fact, Pfizer says these launches should result in $20 billion in sales in 2030.
The March reading comes as investors have continued to scale back their expectations on when the Federal Reserve will cut interest rates in 2024, if at all.
Supreme court rejects petitions seeking return to paper ballots
A teenage boy has been arrested by Gwent Police on suspicion of making threats after Ebbw Fawr Learning Community was placed in lockdown
BASF SE (PNK:BASFY) Q1 2024 Earnings Call Transcript April 25, 2024 Stefanie Wettberg: Good morning, ladies and gentlemen. On behalf of BASF, I would like to welcome you to our conference call on the First Quarter 2024 Results. Throughout today’s recorded presentation, all participants will be in listen-only mode. The presentation will be followed by […]
Fossil fuel and chemical industry lobbyists outnumber several national delegations at the talks in Ottawa
"It dawned on me: They were utterly terrified we were going to discover something very exciting and powerful about our supposedly naughty bodies."
CARLSBAD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced changes to the Board of Directors. Exagen is pleased to announce Scott Kahn, Ph.D. is joining the Board as a Class I Director. Dr. Kahn has a distinguished career in life sciences spending over 30 years in global leadership positions. Prior to starting his career in the life science industry, he was an assistant professor of organic chemistry at the
WEST HOLLYWOOD, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- Bannix Acquisition Corp. (NASDAQ: BNIX) (“Bannix” or the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced that on April 25, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“NASDAQ”) advising the Company that the Company did
MUNICH, Germany, April 26, 2024 (GLOBE NEWSWIRE) -- Sono Group N.V. (the “Company”) (OTC: SEVCF), a solar technology company, today announced a correction to its press release issued on April 25, 2024, which provided an update on the trading symbol for the Company's ordinary shares and introduced the new leadership team. The original press release incorrectly stated that the Company's ordinary shares would be quoted on the over-the-counter market under the U.S. ticker symbol SEVC. Following addi
WASHINGTON, April 26, 2024--Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to U.S. Government agencies, announced today that its Board of Directors has approved a quarterly cash dividend of $0.265 per common share. The dividend will be payable on May 21, 2024 to shareholders of record on May 9, 2024.
TEMPE, Ariz., April 26, 2024--Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it is planning to repurchase $150 million of Align’s common stock through open market repurchases under Align’s $1.0 billion stock repurchase program that was approved by Al
HOUSTON, April 26, 2024--Cheniere Declares Quarterly Dividend
HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.
Boca Raton, Florida, April 26, 2024 (GLOBE NEWSWIRE) -- IB Acquisition Corp. (NASDAQ: IBACU) (the “Company”) announced today that, on May 1, 2024, the Company’s units will no longer trade, and that the Company’s common stock and rights, which together comprise the units will commence trading separately. The common stock and rights will be listed on the Nasdaq Global Market and trade with the ticker symbols “IBAC” and “IBACR”, respectively. This is a mandatory and automatic separation, and no act
The retail market in the United States stands as one of the most prominent and dynamic in the world, boasting key players such as Walmart among its ranks. As per our data, total retail sales in the United States surged to an impressive US$ 7.24 trillion in 2023. This substantial figure underscores the robust consumer demand and market vitality within the nation.NEWARK, Del, April 26, 2024 (GLOBE NEWSWIRE) -- The FMCG logistics market is on its way to marking a valuation of US$ 117.1 billion in 2
April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for theTreatment of Familial Adenomatous Polyposis (FAP) Worldwide rights come with $17 million in non-dilutive grant funding for Pivotal Phase 3 trial in FAP An estimated 100,000 in U.S. and Europe are afflicted with FAP, precancerous polyps that typically lead to surgical removal of the colon and/or rectum In FAP, eRapa holds the potential of delaying or
KUALA LUMPUR, Malaysia, April 26, 2024 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) (“VCI Global”, “VCIG”, or the “Company”), is pleased to announce that it has scheduled an investor conference call at 8:00 a.m. Eastern Time on Tuesday, April 30th, 2024. “We are very excited and look forward to sharing with our investors the growth that our company has seen over this last year,” stated Dato’ Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global. Please call the
OSAKA, Japan & CAMBRIDGE, Mass., April 26, 2024--Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when de
Partnering with Bare Knuckle (BKFC) for “Perry vs. Alves" PPV Event on Saturday, April 27, 2024 PPV Tickets Available for $29.99 at LiveOne.com LiveOne Continues to Dominate Live Streaming with Impressive Milestones: 252,268 PPV Tickets Sold200+ Million Viewers Reached5 Billion Engagements with Fans Across 220 Countries Highlighted PPV Events: Wiz Khalifa, MonsterX, Pitbull Social GlovesFloyd Mayweather vs. Logan PaulFloyd Mayweather vs. DejiIce Wars III: Outlaw EnforcersShowstar UK vs USA: Deji
Yahoo Finance